drugset / Trial / NCT05087615

Effects of Ondansetron, Metoclopramide and Granisetron on Perioperative Nausea and Vomiting in Patients Undergone Bariatric Surgery

NCT05087615

Phase 3 Completed 130 enrolled Shahid Beheshti University of Medical Sciences
RandomizedParallel-groupTriple-blindPrevention

Summary

Post-operative nausea and vomiting (PONV) is one of the leading causes of patient morbidity after laparoscopic bariatric surgeries. A wide variety of complications related to PONV has been described, such as prolonged length of stay (LOS) in hospital, unnecessary readmissions, delay in oral intake, and bad experience for patients. Although several antiemetic regimens have been tried so far in different studies, the incidence of PONV is not significantly lowered, and it seems that it is impossible to totally eliminate it. On the other hand, the implementation of Enhanced Recovery After Surgery (ERAS) has greatly reduced the incidence of PONV and LOS. Therefore, a combination of ERAS and multiple antiemetic regimens is currently used to reduce the incidence of PONV. Nevertheless, the optimal regimen has not been found yet, and many trials are conducting to find out the best antiemetic regimen. In this randomized clinical trial, we compare four different combined and single regimens alongside the implementation of ERAS to show which regimen is more effective.

Timeline

Start
2021-03-01
Primary completion
2021-08-21
Completion
2021-09-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Granisetron Other / unclassified 2 mg Intravenous
Subject Metoclopramide Small molecule 0.2 mg/kg Intravenous
Subject Metoclopramide Small molecule 0.2 mg Intravenous
Subject Ondansetron Other / unclassified 8 mg Intravenous

Indications

No indication recorded.